Bridgepoint Development Capital Recapitalizes Prescient Healthcare Group

January 21, 2021

Bridgepoint Development Capital led a recapitalization of Prescient Healthcare Group, a London-based product strategy consultancy serving the global biopharmaceutical industry; the transaction closed January 19, 2021. Baird Capital (the exiting majority investor) provided a full exit but reinvested as a minority shareholder alongside Bridgepoint to support Prescient's next phase of growth and international expansion.

Targets
Prescient Healthcare Group
Sellers
Baird Capital
Location
England, United Kingdom
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.